# Evonik closes sale of Methacrylates business to Advent International

Evonik has closed the sale of its Methacrylates business to Advent International for €3 billion. The transaction closed on July 31, 2019.

- Type: Acquisition
- Announced: 2019-07-31
- Where: Toronto, Canada
- Value: $3.30B (3.00B EUR)
- Status: completed
- Products: methacrylates
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Evonik](https://endata.com/companies/15139.md)
- [Advent International](https://endata.com/companies/430.md) (acquirer)
- [Evonik](https://endata.com/companies/15139.md) (acquirer)
- [Interface Biologics](https://endata.com/companies/41847.md) (target)

## Sources

- [adhesivesmag.com](https://www.adhesivesmag.com/articles/97148-evonik-closes-sale-of-methacrylates-business-hits-ftc-roadblock-on-peroxychem-acquisition), 2019-08-19: "The sale is a further step in aligning our portfolio towards specialty chemicals and becoming less dependent on economic cycles."
- [medicaldesignandoutsourcing.com](https://www.medicaldesignandoutsourcing.com/evonik-acquires-surface-modification-platform-from-interface-biologics/), 2019-09-03: "We are excited to onboard the Endexo technology in our portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.